PLIVA - Istrazivacki Institut d.o.o

Patent Applications and Registrations

Patent applications and USPTO patent grants for PLIVA - Istrazivacki Institut d.o.o.The latest application filed is for "novel 14 and 15 membered ring compounds".

Company Profile

0.4.24

PLIVA - Istrazivacki Institut d.o.o - Glaxo Group Limited
Pliva-Istrazivacki Institut d.o.o. - Prilaz baruna Filipovica 29 Zagreb HR
Pliva-Istrazivacki Institut d.o.o. - Zagreb HR
Pliva-Istrazivacki Institut d.o.o. - Prilazbaruna Filipovica 29 Zagreb HR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel 14 and 15 Membered Ring Compounds App 20080221158 - Alihodzic; Sulejman ; et al.	2008-09-11
1-Oxadibenzo[e,h]azulenes for the treatment of central nervous system diseases and disorders App 20070173493 - Mercep; Mladen ; et al.	2007-07-26
1,2-Diaza-dibenzo[e,h]azulenes for the treatment of central nervous system diseases and disorders App 20070173492 - Mercep; Mladen ; et al.	2007-07-26
1,3-Diaza-dibenzo[e,h]azulenes for the treatment of central nervous system diseases and disorders App 20070129330 - Mercep; Mladen ; et al.	2007-06-07
1-Aza-2-oxa-dibenzo(e,h)azulenes and their use for the treatment of central nervous system diseases and disorders App 20070078124 - Mercep; Mladen ; et al.	2007-04-05
1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof Grant 7,166,583 - Mercep , et al. January 23, 2	2007-01-23
Ether linked macrolides useful for the treatment of microbial infections App 20060258600 - Alihodzic; Sulejman ; et al.	2006-11-16
Novel semisynthetic macrolide antibiotics of the azalide series App 20060252709 - Kujundzic; Nedjeljko ; et al.	2006-11-09
Use Of 2-thia-dibenzo[e,h]azulenes For The Manufacture Of Pharmaceutical Formulations For The Treatment And Prevention Of Central Nervous System Diseases And Disorders App 20060241099 - Mercep; Mladen ; et al.	2006-10-26
Nonsteroidal anti-inflammatory substances, compositions and methods for their use Grant 7,109,176 - Mercep , et al. September 19, 2	2006-09-19
Use of immune cell specific conjugates for treatment of inflammatory diseases of gastrointestinal tract App 20060183696 - Mercep; Mladen ; et al.	2006-08-17
Compounds, compositions and methods for treatment of inflammatory diseases and conditions Grant 7,091,187 - Mercep , et al. August 15, 2	2006-08-15
Substituted furochromenes, preparation thereof and their antiinflammatory action App 20060148889 - Mercep; Mladen ; et al.	2006-07-06
Substituted 9a-n-[n'-(benzenesulfonyl)carbamoyl-aminopropyl]and 9a-n-[n'-(b-cya-neothyl) -n-[n'-(benzenesulfonyl)carbamoyl-y-aminopropyl]derivatives of 9-deoxo-9-dihydro-9a-aza- 9a-homoerithromycin a and 5-0-aza-homoerithronolide a App 20060084795 - Kujundzic; Nedjelijko ; et al.	2006-04-20
Thiadibenzoazulene derivatives for the treatment of inflammatory diseases App 20060069149 - Mercep; Mladen ; et al.	2006-03-30
Use of immune cell specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract App 20060035845 - Mercep; Mladen ; et al.	2006-02-16
1-Aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof App 20050209191 - Mercep, Mladen ; et al.	2005-09-22
1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof App 20050209214 - Mercep, Mladen ; et al.	2005-09-22
1,2-Diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof App 20050209296 - Mercep, Mladen ; et al.	2005-09-22
O-alkyl macrolide and azalide derivatives and regioselective process for their preparation App 20050164958 - Kidemet, Davor ; et al.	2005-07-28
1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof App 20050148578 - Mercep, Mladen ; et al.	2005-07-07
1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof App 20050148577 - Mercep, Mladen ; et al.	2005-07-07
1-Oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof App 20050148576 - Mercep, Mladen ; et al.	2005-07-07
1- or 3-thia-benzonaphthoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof App 20050130964 - Mercep, Mladen ; et al.	2005-06-16
1-oxa 3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof App 20050130956 - Mercep, Mladen ; et al.	2005-06-16
2- thia-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof App 20050131056 - Mercep, Mladen ; et al.	2005-06-16
Thienodibenzoazulene compounds as tumor necrosis factor inhibitors Grant 6,897,211 - Mercep , et al. May 24, 2	2005-05-24
Solid state forms of 5-(difluoro-methoxy)-2-((3,4-dimethoxy-2-pyridinyl)-m- ethyl) sulfinyl]-1H-benzimidazole sodium aquo complexes App 20050004172 - Filic, Darko ; et al.	2005-01-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.